期刊文献+

VEGF-C在卵巢癌局部淋巴结内淋巴管生成中的作用 被引量:7

Correlation of VEGF-C expression with lymph node lymphangiogenesis in ovarian cancer
原文传递
导出
摘要 目的观察血管内皮生长因子-C(VEGF-C)在卵巢癌组织内的表达,分析其与卵巢癌局部淋巴结内淋巴管生成之间的关系。方法取卵巢癌64例,其中,有淋巴结转移40例,无淋巴结转移24例。应用免疫组化法和Western blot技术观察VEGF-C在卵巢癌组织内的表达。以D2-40作为淋巴管内皮特异性标记物,检测卵巢癌局部淋巴结内淋巴管生成情况。结果 VEGF-C主要表达于卵巢癌细胞浆和胞膜以及癌组织周围浸润的炎性细胞,在有淋巴结转移组的表达率明显高于其在无淋巴结转移组的表达率。Western blot检测结果表明,VEGF-C蛋白在有淋巴结转移的卵巢癌组织中的表达量高于其在无淋巴结转移的卵巢癌组织内的表达量。D2-40表达于卵巢癌局部淋巴结内的淋巴管内皮细胞,在有转移的淋巴结内可见大量新生的淋巴管,淋巴管腔内存在入侵的肿瘤细胞,在无转移的淋巴结内观察到新生的淋巴管。在无淋巴结转移组病例中,卵巢癌组织VEGF-C阳性者局部淋巴结内淋巴管密度明显高于VEGF-C阴性者淋巴结内的淋巴管密度。结论 VEGF-C的表达与卵巢癌淋巴结转移密切相关,卵巢癌在发生局部淋巴结转移之前存在淋巴结内淋巴管生成的现象,卵巢癌组织内VEGF-C的表达在卵巢癌局部淋巴结内的淋巴管生成中可能发挥重要作用。 Objective To investigate the correlation between vascular endothelial growth factor -C (VEGF-C) and lymph node lymphangiogenesis, we observed the expression of VEGF-C in ovarian cancer. Methods Sixty-four paraffin- embedded specimens from patients with ovarian cancer were divided into lymph node metastatic group(n=40) and nonmetastatic group(n=24), 12 metastatically involved lymph nodes and 38 uninvolved lymph nodes. The expressions of VEGF-C were detected by immunohistochemical stain and Western blot. D2-40 was used as the specific lymphatic endothelial marker for detecting lymphangiogenesis in lymph node. Results VEGF-C protein product was observed predominantly in the cytoplasm and membrane of the tumor cells as well as inflammation cells invaded into the tumor, the expression level of VEGF-C was significantly higher in lymph node metastatic group than in nonmetastatic group. D2-40 specifically expressed in lymphatic endothelium in lymph node with ovarian cancer, newly born lymphatic vessels were detected in 12 metastatically involved lymph nodes and in 26 uninvolved lymph nodes. In nonmetastatic group, the lymphatic vessel density(LVD) was significantly higher in VEGF-C positive group than in VEGF-C negative group. Conclusion VEGF-C expression was correlated with lymph node metastasis in ovarian cancer, VEGF-C may play an important role in lymph node lymphangiogenesis in ovarian cancer.
出处 《解剖科学进展》 CAS 2013年第1期5-8,共4页 Progress of Anatomical Sciences
基金 黑龙江省自然科学基金资助项目(No.D201041)
关键词 VEGF—C 淋巴结内淋巴管生成 卵巢癌 VEGF-C lymph node lymphangiogenesis ovarian cancer
  • 相关文献

参考文献10

  • 1张靖,肖建兵,李雪梅,李鑫磊,马晶.血管内皮生长因子C在卵巢上皮癌组织内的表达及其预后意义[J].解剖科学进展,2011,17(6):538-540. 被引量:2
  • 2Gisterek I,Matkowski R,Kozlak J. Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer--10 years followup analysis[J].Anticancer Research,2007,(4C):2797-2802.
  • 3Stacker SA,Caesar C,Baldwin ME. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics[J].Nature Medicine,2001,(02):186-191.
  • 4Qian CN,Berghuis B,Tsarfaty G. Preparing the"soil":the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells[J].Cancer Research,2006,(21):10365-10376.doi:10.1158/0008-5472.CAN-06-2977.
  • 5Weidner N. Angiogenesis as a predictor of clinical outcome in cancer patients[J].Human Pathology,2000,(04):403-405.
  • 6Skobe M,Hawighorst T,Jackson DG. Induction of tumor lymphan giogenesis by VEGF-C promotes breast cancer metastasis[J].Nature Medicine,2001,(02):192-198.
  • 7Harrell MI,Iritani BM,Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis[J].American Journal of Pathology,2007,(02):774-786.doi:10.2353/ajpath.2007.060761.
  • 8Dadras SS,Lange-Asschenfeldt B,Velasco P. Tumor lymphangio genesis predicts melanoma metastasis to sentinel lymph nodes[J].Modern Pathology,2005,(09):1232-1242.
  • 9Van den Eynden GG,Vandenberghe MK,van Dam PJ. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node[J].Clinical Cancer Research,2007,(18 Pt 1):5391-5397.
  • 10Hirakawa S,Brown LF,Kodama S. VEGF-C-induced lymphan giogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites[J].Blood,2007,(03):1010-1017.

二级参考文献9

  • 1赵晓东,张毅.晚期卵巢上皮癌化疗的用药剂量[J].国外医学(妇产科学分册),2005,32(4):235-238. 被引量:4
  • 2Mylona E, Alexandrou P, Mpakali A, et al. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma[J]. Eur J Surg Oncol, 2007, 33(3): 294-300.
  • 3Herrmann E, Ehze E, Bierer S, et al. VEGF-C, VEGF-D and Fit-4in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival[J]. Anticancer Res, 2007, 27(5A): 3127-3133.
  • 4Ueda M, Hung YC, Terai Y, et al. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas[J]. CIin Cancer Res, 2005, 11(9): 3225-3232.
  • 5Yokoyama Y, Charnrk-Jones DS, Licence D, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma[J]. Br J Cancer, 2003, 88(2): 237-244.
  • 6Le T, Alshaikh G, Hopkins L, et al. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking[J]. Ann Surg Oncol, 2006, 13( 12): 1711- 1716.
  • 7曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1999.2129.
  • 8齐斯琴,李丽春,陈明伟,马晶.血管内皮生长因子D在卵巢上皮癌组织内的表达与淋巴结转移的关系[J].解剖科学进展,2009,15(1):47-49. 被引量:1
  • 9王桂芳,侍庆.卵巢上皮性癌142例治疗与预后因素分析[J].实用妇产科杂志,2000,16(3):148-150. 被引量:8

共引文献1

同被引文献79

  • 1周君,刘海玲,陈亦乐,文继舫,李龙,吴晓英.VEGF和miR-205及靶蛋白Ezrin和LaminA/C在卵巢癌中的表达及意义[J].中南大学学报(医学版),2014,39(2):142-150. 被引量:23
  • 2蒋玉萍,吴小华,邢邯英,杜行严.趋化因子CXCL12及其受体CXCR4对卵巢上皮性癌细胞增殖、迁移和侵袭能力的影响[J].中华妇产科杂志,2007,42(6):403-407. 被引量:17
  • 3Achen MG, Je|tsch M, Kukk E, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flkl) atld VEGF receptor 3 (Fh4)[J]. Proc Natl Acad Sci USA, 1998, 95(2): 548-553.
  • 4Yokoyama Y, Charnock-Jones DS, Lieence D, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma[J]. Br J Cancer, 2003, 88(2): 237-244.
  • 5Shida A, Fujioka S, Ishibashi Y, et al. Prognostic significance of vascular endothelial growth factor D in gastric carcinoma[J]. World J Surg, 2005, 29(12): 1600-1607.
  • 6Nakamura Y, Yasuoka H, Tsujimoto M, et al. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up[J]. Clin Cancel Res, 2003, 9(2): 716-721.
  • 7Niki T, Iba S, Tokunou M, et al. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma[J]. Clin Cancer Res, 2000, 6(6): 2431- 2439.
  • 8Strauss L, Volland D, Kunkel M, et al. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance[J]. Med Sci Monit, 2005, 11(8): 280-292.
  • 9Onogawa S, Kitadai Y, Tanaka S, et al. Regulation of vascular endothelial growth factor (VEGF)-C and VEGF-D expression by the organ mieroenvironment in human colon carcinoma[J]. Eur J Cancer, 2004, 40(10): 1604-1609.
  • 10Funaki H, Nishimura G, Harada S, et al. Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma[J]. Oncology, 2003, 64(4): 416-422.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部